HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Neurology
Sys. Review
Narrative review examines immunotherapy options for anti-GQ1b antibody syndromes including BBE and Miller Fisher syndrome
A Rare Brainstem Condition Has a New Diagnostic Map
This narrative review evaluates the role of immunotherapy in patients with anti-GQ1b antibody syndromes, including Bickerstaff Brainstem Enc…
A new model groups rare brain disorders causing double vision and balance problems into one clear spectrum to help doctors diagnose confusin…
Frontiers
Apr 21, 2026
Primary Care & Family Medicine
Sys. Review
Mechanistic review discusses host-directed therapy for children with Long COVID and secondary bacterial pneumonia
Could monitoring specific blood markers help prevent long-term lung damage in kids with Long COVID?
This mechanistic review addresses Long COVID, Post-Acute Sequelae of SARS-CoV-2 infection, and secondary bacterial pneumonia in children.
Monitoring blood markers like ferritin and D-dimer could help doctors catch dangerous lung inflammation early in kids with Long COVID before…
Frontiers
Apr 20, 2026
Allergy & Immunology
Meta-analysis
Systematic review of immunosuppression for SLE-associated intestinal pseudo-obstruction
SLE Can Shut Down the Gut — But It Might Be Reversible
This review synthesized 43 cases of SLE-associated intestinal pseudo-obstruction.
Lupus can paralyze the gut without a blockage, but early treatment with immunosuppressives often reverses this dangerous complication.
Frontiers
Apr 20, 2026
Pediatrics
Meta-analysis
Systematic review and meta-analysis on adjunctive corticosteroids for orbital cellulitis in children
Steroids Help Kids With Eye Infections
This systematic review and meta-analysis evaluates the effectiveness and safety of adjunctive systemic corticosteroids compared with antibio…
Steroids may safely speed recovery for kids with serious eye infections, reducing swelling and pain without hiding the infection.
Frontiers
Apr 20, 2026
Orthopedics & Sports Medicine
Guideline
Scoping review synthesizes immunosuppressive strategies and outcomes in solid organ transplantation
New Drug Strategies Aim to Stop Your Body From Rejecting a Transplant
This scoping review examines immunosuppressive strategies for solid organ transplant patients, including conventional, biologic, and emergin…
New drug strategies aim to stop your body from attacking a new organ, protecting transplants longer while reducing dangerous side effects fr…
Frontiers
Apr 20, 2026
Rheumatology
Cohort
POEM in Allgrove syndrome shows earlier symptom onset and favorable outcomes versus idiopathic achalasia
New Hope for Rare Childhood Disorder Affecting Eating
This cohort study from Peking Union Medical College Hospital, China, compared peroral endoscopic myotomy (POEM) outcomes in 7 patients with …
A minimally invasive procedure now helps children with rare Allgrove syndrome eat without pain, offering long-term relief for those who once…
Frontiers
Apr 18, 2026
Neurology
Cohort
Systemic corticosteroids associated with greater hearing gain than intratympanic therapy in idiopathic SSNHL
Systemic steroids beat ear drops for sudden hearing loss
This single-center retrospective cohort study evaluated 284 adults with idiopathic sudden sensorineural hearing loss comparing initial syste…
Taking steroids by mouth or IV works better than putting them in the ear for sudden hearing loss.
Frontiers
Apr 16, 2026
Allergy & Immunology
Cohort
VEXAS Syndrome Clinical Features and Treatment Outcomes in a Chinese Cohort of 16 Patients
Small study links UBA1 gene variants to blood and inflammatory issues in China
This retrospective cohort study of 16 Chinese patients describes main clinical features and treatment responses in VEXAS syndrome.
A specific genetic change called a UBA1 variant was found in 81 percent of patients in China with blood disorders and inflammation affecting…
Frontiers
Apr 16, 2026
Drug Pipeline
RCT
Guselkumab showed improved clinical remission in refractory ulcerative colitis versus placebo
Guselkumab shows promise for ulcerative colitis in this early phase 3 trial
This phase 3 randomized trial evaluated guselkumab in adults with moderately to severely active ulcerative colitis who had inadequate respon…
Patients with ulcerative colitis who failed other treatments achieved remission in a new trial using subcutaneous guselkumab injections.
Apr 15, 2026
Pediatrics
Sys. Review
Case report details KFD patient developing SLE treated with immunosuppression
Your stomach hurts. You throw up. You think it is just food poisoning. But what if your immune system is fighting a hidden battle inside your lymph nodes? This story is about a rare condition that tricks doctors and changes a patient's life forever
This case report describes a single patient with Kikuchi-Fujimoto disease who subsequently developed systemic lupus erythematosus.
Severe stomach pain and vomiting from a rare immune disorder can hide a hidden battle in your lymph nodes that tricks doctors into missing t…
Frontiers
Apr 15, 2026
Pediatrics
Sys. Review
A single case report confirms rare IgE-mediated cocoa allergy causing anaphylaxis in a child
Your Child's Chocolate Reaction Might Not Be Milk or Nuts
This systematic review and case report describes a 2-year-old female with a history of allergic rhinitis and tree nut anaphylaxis who experi…
Most chocolate reactions aren't the cocoa itself, but a rare toddler case proves true cocoa allergies exist and require careful testing to f…
Frontiers
Apr 14, 2026
Allergy & Immunology
Sys. Review
Strategies to screen and reduce adverse events in patients with asthma using systemic corticosteroids
Asthma Patients Are Still Getting Too Many Steroids — Here Is Why That Matters
This systematic review examined real-world practice strategies aimed at identifying and screening patients at risk of adverse events associa…
Asthma patients face serious, preventable harm from overused systemic steroids, yet safer biologics aren't reaching enough people who need t…
Frontiers
Apr 14, 2026